The role of androgens in hormone replacement therapy

Crista Johnson, Jennifer R. Berman

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

In recent years, increased attention to women's sexual health has propelled basic scientific research and clinical trials investigating treatment paradigms for improving sexual well-being. As the prevalence of female sexual dysfunction has become manifest, knowledge of the intricate pathophysiological role of androgens in maintaining sexual function has fostered a clearer understanding of the effect of age on androgen status, the role of androgens in the postmenopausal ovary, and aetiological mechanisms of androgen insufficiency in premenopausal and postmenopausal women. Understanding the long-term safety and efficacy of physiological androgen replacement and the development of sensitive testosterone assays for specific use in women will better characterise women who are most likely to respond to androgen therapy and, thereby, optimise their quality of life.

Original languageEnglish (US)
Pages (from-to)1815-1831
Number of pages17
JournalExpert Opinion on Pharmacotherapy
Volume6
Issue number11
DOIs
StatePublished - Sep 1 2005
Externally publishedYes

Fingerprint

Hormone Replacement Therapy
Androgens
Reproductive Health
Women's Health
Testosterone
Ovary
Quality of Life
Clinical Trials
Safety
Therapeutics
Research

Keywords

  • Androgen insufficiency
  • Androgens
  • Androstenedione
  • Dehydroepiandrosterone
  • Dehydroepiandrosterone sulfate
  • Dihydrotestosterone
  • Female sexual dysfunction
  • Hormone replacement therapy
  • Hypoactive sexual desire disorder
  • Menopause
  • Oestrogen
  • Testosterone

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

The role of androgens in hormone replacement therapy. / Johnson, Crista; Berman, Jennifer R.

In: Expert Opinion on Pharmacotherapy, Vol. 6, No. 11, 01.09.2005, p. 1815-1831.

Research output: Contribution to journalReview article

Johnson, Crista ; Berman, Jennifer R. / The role of androgens in hormone replacement therapy. In: Expert Opinion on Pharmacotherapy. 2005 ; Vol. 6, No. 11. pp. 1815-1831.
@article{cf5a9ecd3f404062b62b4d827e0a6d5b,
title = "The role of androgens in hormone replacement therapy",
abstract = "In recent years, increased attention to women's sexual health has propelled basic scientific research and clinical trials investigating treatment paradigms for improving sexual well-being. As the prevalence of female sexual dysfunction has become manifest, knowledge of the intricate pathophysiological role of androgens in maintaining sexual function has fostered a clearer understanding of the effect of age on androgen status, the role of androgens in the postmenopausal ovary, and aetiological mechanisms of androgen insufficiency in premenopausal and postmenopausal women. Understanding the long-term safety and efficacy of physiological androgen replacement and the development of sensitive testosterone assays for specific use in women will better characterise women who are most likely to respond to androgen therapy and, thereby, optimise their quality of life.",
keywords = "Androgen insufficiency, Androgens, Androstenedione, Dehydroepiandrosterone, Dehydroepiandrosterone sulfate, Dihydrotestosterone, Female sexual dysfunction, Hormone replacement therapy, Hypoactive sexual desire disorder, Menopause, Oestrogen, Testosterone",
author = "Crista Johnson and Berman, {Jennifer R.}",
year = "2005",
month = "9",
day = "1",
doi = "10.1517/14656566.6.11.1815",
language = "English (US)",
volume = "6",
pages = "1815--1831",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "11",

}

TY - JOUR

T1 - The role of androgens in hormone replacement therapy

AU - Johnson, Crista

AU - Berman, Jennifer R.

PY - 2005/9/1

Y1 - 2005/9/1

N2 - In recent years, increased attention to women's sexual health has propelled basic scientific research and clinical trials investigating treatment paradigms for improving sexual well-being. As the prevalence of female sexual dysfunction has become manifest, knowledge of the intricate pathophysiological role of androgens in maintaining sexual function has fostered a clearer understanding of the effect of age on androgen status, the role of androgens in the postmenopausal ovary, and aetiological mechanisms of androgen insufficiency in premenopausal and postmenopausal women. Understanding the long-term safety and efficacy of physiological androgen replacement and the development of sensitive testosterone assays for specific use in women will better characterise women who are most likely to respond to androgen therapy and, thereby, optimise their quality of life.

AB - In recent years, increased attention to women's sexual health has propelled basic scientific research and clinical trials investigating treatment paradigms for improving sexual well-being. As the prevalence of female sexual dysfunction has become manifest, knowledge of the intricate pathophysiological role of androgens in maintaining sexual function has fostered a clearer understanding of the effect of age on androgen status, the role of androgens in the postmenopausal ovary, and aetiological mechanisms of androgen insufficiency in premenopausal and postmenopausal women. Understanding the long-term safety and efficacy of physiological androgen replacement and the development of sensitive testosterone assays for specific use in women will better characterise women who are most likely to respond to androgen therapy and, thereby, optimise their quality of life.

KW - Androgen insufficiency

KW - Androgens

KW - Androstenedione

KW - Dehydroepiandrosterone

KW - Dehydroepiandrosterone sulfate

KW - Dihydrotestosterone

KW - Female sexual dysfunction

KW - Hormone replacement therapy

KW - Hypoactive sexual desire disorder

KW - Menopause

KW - Oestrogen

KW - Testosterone

UR - http://www.scopus.com/inward/record.url?scp=25444450825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25444450825&partnerID=8YFLogxK

U2 - 10.1517/14656566.6.11.1815

DO - 10.1517/14656566.6.11.1815

M3 - Review article

C2 - 16144503

AN - SCOPUS:25444450825

VL - 6

SP - 1815

EP - 1831

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 11

ER -